Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-018975-13Phase 2Active
Phase 2 trial of rosa canina in hip osteoarthritis, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Anti-dolorific activity of Rosa canina extract. Started Apr 2012; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-018975-13.